CuePath Innovation
Techstars '17Vancouver, CA · British Columbia, Canada corporation · 1 known investors
CuePath develops smart stickers that attach to medication blister packs to monitor and record real-time adherence data for clinical drug trials. The technology targets clinical research organizations and serves substance use disorder and addiction management studies across North America.
Enterprise SoftwareHealthtechIoTMedical Devices
Founders & leadership
KM
Kirk MoirNamed on SEC filing
GA
Geof AuchinleckNamed on SEC filing
KD
Ken D. PiaggioNamed on SEC filing
JT
Jennifer ThompsonNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$59K disclosed across 1 round · 2022
▶$59KraisedNov 2022 · 2 investors · Other Health CareRule 506(b)
▶$59KraisedNov 2022 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kirk MoirDirector
- Geof AuchinleckDirector
- Ken D. PiaggioExecutive Officer
- Jennifer ThompsonDirector
- Offering amount
- $80.9K
- Amount sold
- $59K
- Minimum investment
- $11.8K
- First sale
- Mar 2022
- Incorporated
- Corporation, British Columbia, Canada
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does CuePath Innovation do?
- CuePath develops smart stickers that attach to medication blister packs to monitor and record real-time adherence data for clinical drug trials. The technology targets clinical research organizations and serves substance use disorder and addiction management studies across North America.
- Who are CuePath Innovation's investors?
- CuePath Innovation's investors include Techstars.
- How much funding has CuePath Innovation raised?
- CuePath Innovation has disclosed $59K raised across 1 round.
- Where is CuePath Innovation headquartered?
- CuePath Innovation is headquartered in Vancouver, CA.